Intestinal Permeability in Non-alcoholic Fatty LIVER Disease: The Gut-liver Axis

被引:28
|
作者
Scarpellini, E. [1 ]
Lupo, M. [2 ]
Iegri, C. [2 ]
Gasbarrini, A. [3 ]
De Santis, A. [2 ]
Tack, J. [1 ]
机构
[1] KULeuven, TARGID, Leuven, Belgium
[2] Sapienza Univ Rome, Umberto I Univ Hosp, Div Gastroenterol, Rome, Italy
[3] Gemelli Univ Hosp, Internal Med & Gastroenterol Div, Rome, Italy
关键词
Intestinal permeability; zonulin-1; claudin; nafld; nash; lipopolysaccharide;
D O I
10.2174/1574887109666141216104334
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The gut-liver axis model has helped to explain the liver steatosis (NAFLD) and steatohepatitis (NASH) etiopathogenesis. The discovery of a key role for an altered intestinal permeability (IP) in this pathophysioligcal framework has closed the link between gut lumen antigenic/toxic substances and systemic and liver inflammation in NAFLD and obesity, metabolic syndrome. Recent evidence from the literature show how IP can be modulated by several non-pharmacological and pharmacological agents and be the target for future preventive and curative treatment of NAFLD and NASH. In this review we describe the concept of IP, its ultrastructural basis, its role in the NALFD pathophysiology and emerging evidence on non-pharmacological and pharmacological agents able to favourably modulate it.
引用
收藏
页码:141 / 147
页数:7
相关论文
共 50 条
  • [21] The Gut-Liver Axis in Nonalcoholic Fatty Liver Disease: Association of Intestinal Permeability with Disease Severity and Treatment Outcomes
    Zhuang, Yu-Pei
    Zhang, Yi-Ting
    Zhang, Ruo-Xin
    Zhong, Hao-Jie
    He, Xing-Xiang
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2022, 2022 : 4797453
  • [22] MODULATION OF INTESTINAL MICROBIOTA AND GUT-LIVER AXIS BY QUERCETIN IMPROVE HFD-INDUCED METABOLIC SYNDROME AND NON-ALCOHOLIC FATTY LIVER DISEASE IN MICE
    Porras-Sanabria, D.
    Garcia-Mediavilla, M. V.
    Martinez-Florez, S.
    Nistal, E.
    Olcoz, J. L.
    Jover, R.
    Gonzalez-Gallego, J.
    Sanchez-Campos, S.
    JOURNAL OF HEPATOLOGY, 2016, 64 : S677 - S677
  • [23] The liver X receptor: A master regulator of the gut-liver axis and a target for non alcoholic fatty liver disease
    Ducheix, Simon
    Montagner, Alexandra
    Theodorou, Vassilia
    Ferrier, Laurent
    Guillou, Herve
    BIOCHEMICAL PHARMACOLOGY, 2013, 86 (01) : 96 - 105
  • [24] Intestinal hormones, gut microbiota and non-alcoholic fatty liver disease
    Koukias, Nikolaos
    Buzzetti, Elena
    Tsochatzis, Emmanuel A.
    MINERVA ENDOCRINOLOGICA, 2017, 42 (02) : 184 - 194
  • [25] The Molecular and Mechanistic Insights Based on Gut-Liver Axis: Nutritional Target for Non-Alcoholic Fatty Liver Disease (NAFLD) Improvement
    Ji, Yun
    Yin, Yue
    Sun, Lijun
    Zhang, Weizhen
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (09)
  • [26] Naturally Occurring Stilbenoid TSG Reverses Non-Alcoholic Fatty Liver Diseases via Gut-Liver Axis
    Lin, Pei
    Lu, Jianmei
    Wang, Yanfang
    Gu, Wen
    Yu, Jie
    Zhao, Ronghua
    PLOS ONE, 2015, 10 (10):
  • [27] Viral Liver Disease and Intestinal Gut-Liver Axis
    Kouroumalis, Elias
    Tsomidis, Ioannis
    Voumvouraki, Argyro
    GASTROINTESTINAL DISORDERS, 2024, 6 (01): : 64 - 93
  • [28] Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation
    Nicoletti, Alberto
    Ponziani, Francesca Romana
    Biolato, Marco
    Valenza, Venanzio
    Marrone, Giuseppe
    Sganga, Gabriele
    Gasbarrini, Antonio
    Miele, Luca
    Grieco, Antonio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2019, 25 (33) : 4814 - 4834
  • [29] Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation
    Alberto Nicoletti
    Francesca Romana Ponziani
    Marco Biolato
    Venanzio Valenza
    Giuseppe Marrone
    Gabriele Sganga
    Antonio Gasbarrini
    Luca Miele
    Antonio Grieco
    World Journal of Gastroenterology, 2019, (33) : 4814 - 4834
  • [30] The gut-liver nexus: exploring gut microbiota dysbiosis in non-alcoholic fatty liver disease and its therapeutic implications
    Swamikkannu, Dinesh Mohan
    Dasarapu, Santhosha
    Siva, Rajendra Prasad Velivela
    Nallam, Javali
    Pabba, Satvika
    EGYPTIAN LIVER JOURNAL, 2024, 14 (01)